Author:
Ngayo Musa Otieno,Oluka Margaret,Bulimo Wallace Dimbuson,Okalebo Faith Apolot
Abstract
AbstractHIV-related stigma, lack of disclosure and social support are still hindrances to HIV testing, care, and prevention. We assessed the association of these social-psychological statuses with nevirapine (NVP) and efavirenz (EFV) plasma concentrations among HIV patients in Kenya. Blood samples were obtained from 254 and 312 consenting HIV patients on NVP- and EFV-based first-line antiretroviral therapy (ART), respectively, and a detailed structured questionnaire was administered. The ARV plasma concentration was measured by liquid chromatography-tandem mass spectrometry (LC–MS/MS). There were 68.1% and 65.4% of the patients on NVP and EFV, respectively, who did not feel guilty for being HIV positive. The disclosure rates were approximately 96.1% and 94.6% of patients on NVP and EFV, respectively. Approximately 85% and 78.2% of patients on NVP and EFV, respectively, received social support as much as needed. There were 54.3% and 14.2% compared to 31.7% and 4.5% patients on NVP and EFV, respectively, with supratherapeutic and suboptimal plasma concentrations. Multivariate quantile regression analysis showed that feeling guilty for being HIV positive was associated with increased 954 ng/mL NVP plasma concentrations (95% CI 192.7 to 2156.6; p = 0.014) but not associated with EFV plasma concentrations (adjusted β = 347.7, 95% CI = − 153.4 to 848.7; p = 0.173). Feeling worthless for being HIV positive was associated with increased NVP plasma concentrations (adjusted β = 852, 95% CI = 64.3 to 1639.7; p = 0.034) and not with EFV plasma concentrations (adjusted β = − 143.3, 95% CI = − 759.2 to 472.5; p = 0.647). Being certain of telling the primary sexual partner about HIV-positive status was associated with increased EFV plasma concentrations (adjusted β 363, 95% CI, 97.9 to 628.1; p = 0.007) but not with NVP plasma concentrations (adjusted β = 341.5, 95% CI = − 1357 to 2040; p = 0.692). Disclosing HIV status to neighbors was associated with increased NVP plasma concentrations (adjusted β = 1731, 95% CI = 376 to 3086; p = 0.012) but not with EFV plasma concentrations (adjusted β = − 251, 95% CI = − 1714.1 to 1212.1; p = 0.736). Obtaining transportation to the hospital whenever needed was associated with a reduction in NVP plasma concentrations (adjusted β = − 1143.3, 95% CI = − 1914.3 to − 372.4; p = 0.004) but not with EFV plasma concentrations (adjusted β = − 6.6, 95% CI = − 377.8 to 364.7; p = 0.972). HIV stigma, lack disclosure and inadequate social support are still experienced by HIV-infected patients in Kenya. A significant proportion of patients receiving the NVP-based regimen had supra- and subtherapeutic plasma concentrations compared to EFV. Social-psychological factors negatively impact adherence and are associated with increased NVP plasma concentration compared to EFV.
Publisher
Springer Science and Business Media LLC
Reference48 articles.
1. UNAIDS. 2020. Global AIDS update 2020. Seizing the Moment. Tackling entrenched Inequalities to end epidemics. Available https://www.unaids.org/sites/default/files/media_asset/2020_global-aids-report_en.pdf. Accessed August 16, 2020.
2. WHO. HIV/AIDS Psychosocial Support. Available at https://www.who.int/hiv/topics/psychosocial/support/en/#references. Accessed March 7, 2021.
3. Okonji, E. F., Mukumbang, F. C., Orth, Z., Vickerman-Delport, S. A. & Van Wyk, B. Psychosocial support interventions for improved adherence and retention in ART care for young people living with HIV (10–24 years): A scoping review. BMC Public Health 20(1), 1841 (2020).
4. Kose, S., Mandiracioglu, A., Mermut, G., Kaptan, E. & Ozbel, Y. The social and health problems of people living with HIV/ AIDS in Izmir. Turkey. EAJM. 44, 32–39 (2012).
5. Mbonu, N. C., van den Borne, B. & De Vries, N. Stigma of people with HIV/AIDS in Sub-Saharan Africa: A literature review. J. Trop. Med. 14, 1–14 (2009).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献